Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Solid Tumor × Interleukin-2 × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 4 Uveal Melanoma 3 Solid Tumors 1 Solid Tumor 1 Ovarian Neoplasms 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1

Interventions

apatinib 2 phosphorylethanolamine 1 fludarabine 1 camrelizumab 1 Interleukin-2 1 Injections 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05649618 2022-12-14

TIL Cells for the Treatment of the Advanced Solid Tumors Patients

Fujian Cancer Hospital

Phase EARLY_PHASE1 Not yet recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡